-
Mashup Score: 21Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma - 8 month(s) ago
Patient-reported outcomes provide an important measure of health-related quality of life and can complement efficacy and safety results. This article presents a
Source: academic.oup.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Recent advances in digital pathology have enabled accurate and standardised enumeration of tumour-infiltrating lymphocytes (TILs). Here, we aim to eva…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 2What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract - 2 year(s) ago
World Bladder Cancer Patient Coalition, therapy combinations for patients with urothelial cancer, chemotherapy options for patients with muscle-invasive bladder cancer, bladder cancer patient advocacy groups, patient involvement at bladder cancer congresses.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did we learn from #ESMO21, and what’s next? A peer-reviewed #podcast with a patient advocate and physician. #BeyondTheAbstract with @filicevas @WorldBladderCan and @tompowles1 @QMBCI. #ReadNow and listen today! > https://t.co/mMJsPQ836A @AllCanGroup @Oncology_Ther @myESMO https://t.co/ZyJhEDaPaw
-
-
Mashup Score: 0What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract - 2 year(s) ago
World Bladder Cancer Patient Coalition, therapy combinations for patients with urothelial cancer, chemotherapy options for patients with muscle-invasive bladder cancer, bladder cancer patient advocacy groups, patient involvement at bladder cancer congresses.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did we learn from #ESMO21, and what’s next? A peer-reviewed #podcast with a patient advocate and physician. #BeyondTheAbstract with @filicevas @WorldBladderCan and @tompowles1 @QMBCI. #ReadNow and listen today! > https://t.co/mMJsPQpEva @AllCanGroup @Oncology_Ther @myESMO https://t.co/Maf3eyxch4
-
-
Mashup Score: 3ESMO 2022: 8-Month PSA Strongly Predicts Outcomes of Men with Metastatic Castration-Sensitive Prostate Cancer in the PEACE-1 Phase 3 Trial - 2 year(s) ago
ESMO 2022 8-month PSA decline to undetectable levels, EACE-1 phase 3 trial, ADT plus docetaxel or abiraterone acetate plus prednisone, men with de novo mCSPC in the PEACE-1 phase 3 trial, ADT+/- docetaxel +/- abiraterone acetate + prednisone.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract - 2 year(s) ago
World Bladder Cancer Patient Coalition, therapy combinations for patients with urothelial cancer, chemotherapy options for patients with muscle-invasive bladder cancer, bladder cancer patient advocacy groups, patient involvement at bladder cancer congresses.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did we learn from #ESMO21, and what’s next? A peer-reviewed #podcast with a patient advocate and physician. #BeyondTheAbstract with @filicevas @WorldBladderCan and @tompowles1 @QMBCI. #ReadNow and listen today! > https://t.co/mMJsPQqckI @AllCanGroup @Oncology_Ther @myESMO https://t.co/tJYdiu3hC3
-
-
Mashup Score: 0What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract - 2 year(s) ago
World Bladder Cancer Patient Coalition, therapy combinations for patients with urothelial cancer, chemotherapy options for patients with muscle-invasive bladder cancer, bladder cancer patient advocacy groups, patient involvement at bladder cancer congresses.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did we learn from #ESMO21, and what’s next? A peer-reviewed #podcast with a patient advocate and physician. #BeyondTheAbstract with @filicevas @WorldBladderCan and @tompowles1 @QMBCI. #ReadNow and listen today! > https://t.co/mMJsPQpEva @AllCanGroup @Oncology_Ther @myESMO https://t.co/aEUrwtccLA
-
-
Mashup Score: 0What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract - 2 year(s) ago
World Bladder Cancer Patient Coalition, therapy combinations for patients with urothelial cancer, chemotherapy options for patients with muscle-invasive bladder cancer, bladder cancer patient advocacy groups, patient involvement at bladder cancer congresses.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did we learn from #ESMO21, and what’s next? A peer-reviewed #podcast with a patient advocate and physician. #BeyondTheAbstract with @filicevas @WorldBladderCan and @tompowles1 @QMBCI. #ReadNow and listen today! > https://t.co/mMJsPQpEva @AllCanGroup @Oncology_Ther @myESMO https://t.co/3Qbf3iQZpT
-
-
Mashup Score: 0What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract - 2 year(s) ago
World Bladder Cancer Patient Coalition, therapy combinations for patients with urothelial cancer, chemotherapy options for patients with muscle-invasive bladder cancer, bladder cancer patient advocacy groups, patient involvement at bladder cancer congresses.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did we learn from #ESMO21, and what’s next? A peer-reviewed #podcast with a patient advocate and physician. #BeyondTheAbstract with @filicevas @WorldBladderCan and @tompowles1 @QMBCI. #ReadNow and listen today! > https://t.co/mMJsPQpEva @AllCanGroup @Oncology_Ther @myESMO https://t.co/ahSFjrjd5T
-
-
Mashup Score: 1What Did We Learn from ESMO 2021, and What’s Next? A Peer-Reviewed Podcast with a Patient Advocate and Physician - Beyond the Abstract - 2 year(s) ago
World Bladder Cancer Patient Coalition, therapy combinations for patients with urothelial cancer, chemotherapy options for patients with muscle-invasive bladder cancer, bladder cancer patient advocacy groups, patient involvement at bladder cancer congresses.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did we learn from #ESMO21, and what’s next? A peer-reviewed #podcast with a patient advocate and physician. #BeyondTheAbstract with @filicevas @WorldBladderCan and @tompowles1 @QMBCI. #ReadNow and listen today! > https://t.co/mMJsPQpEva @AllCanGroup @Oncology_Ther @myESMO https://t.co/Y6MWWzXTSL
-
Now in the @OncJournal after #ESMO21 @myESMO: Pembrolizumab QOL in resected RCC from KYN-564 with many colleagues, like @tompowles1 et al https://t.co/SUg0O57RbU @OncoAlert @OncBrothers https://t.co/c4R2zZMfMD